The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global pandemic by the World Health Organization in March 2020 and since then, it has caused huge economic and social turmoil worldwide . In an attempt to reduce the spread across the United States (U.S.) and worldwide, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of different vaccines (BNT-162b2, mRNA-1273, and Ad26.COV2. S).Int J Anaesth Crit Care, 2023, Volume 2, Issue 1, p1-4 | DOI: 10.33696/Anesthesia.2.006
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.